Abstract:Cytochrome P450 (CYP450) belongs to a family of self-oxidizing heme proteins and serves as a key metabolic enzyme in the body, playing a central role in drug metabolism. Some CYP450 family members are specifically expressed in the central nervous system, where they regulate the metabolism of endogenous active substances and psychoactive drugs, thereby playing physiological and pathological functions. Recent studies have revealed that certain CYP450 subtypes (such as CYP2J6, CYP26A1, CYP2D6, and CYP3A4) play critical regulatory roles in the development of inflammatory and neuropathic pain by metabolizing endogenous lipid mediators (such as eicosanoid-like substances) and exogenous compounds (such as clinical drugs). However, several important questions remain unresolved: the roles of other CYP450 family members in chronic pain are still unclear; potential synergistic or antagonistic effects among different subtypes need to be elucidated; and the mechanisms by which individual genetic differences affect pain perception and drug response require further exploration. This paper systematically reviews the structural characteristics, tissue distribution, and metabolic networks of the CYP450 enzyme system, with a focus on recent advances in chronic pain research. It also discusses potential pain treatment strategies targeting CYP450, aiming to provide new ideas and theoretical foundations for developing precise analgesic approaches.